Top Science Scandals of 2014

The stem cell that never was; post-publication peer review website faces legal trouble; biosecurity breaches at federal labs

Written byJef Akst
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

As always, in addition to the scientific breakthroughs that make headlines throughout the year, there is also a dark side to science. From misconduct to human error, there is always the possibility for something to go wrong. This year saw the announcement and retraction of a new method of cellular reprogramming; a lawsuit against users of an anonymous post-publication peer review website; and multiple biosecurity breakdowns at federal facilities.

The STAP saga

HARUKO OBOKATAThis January, Haruko Obokata of the RIKEN Center for Developmental Biology in Kobe, Japan, along with her colleagues published two papers in Nature that described pluripotent stem cells that had been derived simply by applying a physical stressor to adult cells. Known as stimulus-triggered acquisition of pluripotency, or STAP, the findings attracted the attention of the scientific community and media. But it didn’t take long for some researchers to raise questions.

Scientist bloggers led the way, posting the results of their attempts to replicate the study in real time. Users of the post-publication peer review website PubPeer also raised concerns. By February, RIKEN had launched its own investigation, which led to a finding of scientific misconduct against Obokata. In July, Nature retracted both papers. ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • Jef (an unusual nickname for Jennifer) got her master’s degree from Indiana University in April 2009 studying the mating behavior of seahorses. After four years of diving off the Gulf Coast of Tampa and performing behavioral experiments at the Tennessee Aquarium in Chattanooga, she left research to pursue a career in science writing. As The Scientist's managing editor, Jef edited features and oversaw the production of the TS Digest and quarterly print magazine. In 2022, her feature on uterus transplantation earned first place in the trade category of the Awards for Excellence in Health Care Journalism. She is a member of the National Association of Science Writers.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies